Aymes   Report issue

For profit
Founded: Haywards Heath United Kingdom (2008)
Status: No NME R&D (2008)

Organization Overview

First Clinical Trial
2017
NCT03834896
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Aymes International Limited

Active Ingredients

Drugs in Other Trials (1)

aymes madrid (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1